Loading
Prestige Consumer Healthcare Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by P'Pool William, was filed 12 Feb 2018.
Insider Decl.
482
Thresholds
n/a
Buy Volume
€666,785
5 ops. · all time
Sell Volume
€44M
70 ops. · all time
Who traded when
BuySaleMary Beth Fritz4 sales
Ronald M. Lombardi4 sales
Adel Mekhail3 sales
Jeffrey Zerillo3 sales
Christine Sacco1 sale
John E. Byom1 sale
+1 other insider
Since the insiders bought
- -12.8%Entry US$32.94 · Close at T+365 US$28.73
- -16.3%Entry US$33.76 · Close at T+365 US$28.27
- -26.8%Entry US$36.89 · Close at T+365 US$27.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,664 of 26,250 companies
68.3
score / 100
Value73
Quality64
FCF yld11%
Earn yld8.4%
EV/EBITDA10.0x
ROE9.1%
Gross mgn55%
Net mgn17%
Debt/EBITDA3.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
US$47.92
Analyst consensus
5 analysts1.71/5
US$55.00Target US$67.80(+41%)US$75.00
Income statement
RevenueUS$1.1B
Gross profitUS$595.6M55% margin
EBITDAUS$331.1M30% margin
Net incomeUS$190.3M15.6% margin
Valuation
PER (trailing)13.4x
PER (forward)9.4x
P/Book1.2x
Beta0.34
Balance sheet & cash
Market capUS$2.3B
Total debtUS$1B
Free Cash FlowUS$246.4M
Debt / Equity108%
Profitability & ownership
ROE9.1%
ROA4.6%
% insiders1.4%
% institutions116.6%
Last declaration on 5 August 2026
Declarations482 total
2,981 shares0Common Stock, par value $0.01 per shareSEC:0001104659-26-091081:0
2,981 shares0Common Stock, par value $0.01 per shareSEC:0001104659-26-091082:0
2,981 shares0Common Stock, par value $0.01 per shareSEC:0001104659-26-091084:0
2,981 shares0Common Stock, par value $0.01 per shareSEC:0001104659-26-091086:0
2,981 shares0Common Stock, par value $0.01 per shareSEC:0001104659-26-091079:0
1,091 shares@ US$55.090.0023% mcap20.3% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-26-061137:0
1,000 shares@ US$65.9312.6% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-26-015275:0
3,426 shares0Common Stock, par value $0.01 per shareSEC:0001104659-26-007965:0
281 shares@ US$60.001.1% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-25-117754:1
719 shares@ US$60.0031.2% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-25-117754:0
3,000 shares@ US$59.35100.0% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-25-116419:0
2,094 shares0Common Stock, par value $0.01 per shareSEC:0001104659-25-074704:0
2,094 shares0Common Stock, par value $0.01 per shareSEC:0001104659-25-074694:0
2,094 shares0Common Stock, par value $0.01 per shareSEC:0001104659-25-074710:0
2,094 shares0Common Stock, par value $0.01 per shareSEC:0001104659-25-074707:0
2,094 shares0Common Stock, par value $0.01 per shareSEC:0001104659-25-074702:0
2,094 shares0Common Stock, par value $0.01 per shareSEC:0001104659-25-074697:0
990 shares@ US$81.410.6% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-25-046857:1
457 shares@ US$81.413.2% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-25-046859:0
7,775 shares0Common Stock, par value $0.01 per shareSEC:0001104659-25-046857:0
354 shares@ US$81.415.8% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-25-046856:0
315 shares@ US$81.411.4% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-25-046854:0
2,305 shares@ US$81.412.8% of flowCommon Stock, par value $0.01 per shareSEC:0001104659-25-046860:0
1,837 shares0Common Stock, par value $0.01 per shareSEC:0001104659-25-045720:0
12,352 shares0Common Stock, par value $0.01 per shareSEC:0001104659-25-045722:0
25 of 482 declarations
About Prestige Consumer Healthcare Inc.
On February 5, 2018, Gary E. Costley, a Director of Prestige Consumer Healthcare Inc., bought EUR 213,727, Ronald M. Lombardi, Chief Executive Officer, EUR 202,122 and James M. Jenness, Director, EUR 119,687. From February 5 to February 12, 2018, 5 filers bought for EUR 666,785, all 5 of the purchases in the record (median EUR 119,687).
The 70 sales weigh EUR 43.9 million, with a median of EUR 441,283. Ronald M. Lombardi holds the three largest: EUR 3,807,276 and EUR 2,638,451 on November 18, 2024, and EUR 2,871,061 on November 12, 2021. Lombardi signs 70 of the 482 filings, 1 of them a purchase and 11 sales.
Read moreShow less
This US healthcare and pharma company is valued at USD 2.3 billion. Mary Beth Fritz, SVP Quality & Regulatory, is the most frequent filer with 76 filings; Christine Sacco, CFO & COO, signs 56 and William P'Pool 54. Grants account for 349 filings, option exercises for 56. Annual volume reaches 93 in 2024, against 24 in 2017. Over the last twelve months: 11 filings, of which 4 sales and no purchase.
